Error: Could not add to watchlist. X
+ Watchlist

SciClone Pharmaceuticals Inc

SCLN:US
Acquired
SCLN:US was acquired by
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
0.87
Market Cap (USD)
-
Shares Outstanding (m)
52.192
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.29%
% Price Change
+0.31%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
SciClone Pharmaceuticals, Inc. is a global biopharmaceutical company. The Company acquires, develops, and commercializes drugs for treating chronic and life-threatening diseases such as cancer, hepatitis B, hepatitis C, cystic fibrosis, and immune system disorders. SciClone Pharmaceuticals serves the healthcare sector in China.
Address
950 Tower Lane
Suite 900
Foster City, CA 94404
United States
Phone
1-650-358-3456
Show More